Latest News and Press Releases

Copenhagen, Denmark, 23 April 2025 – Antag Therapeutics (“Antag” or “the Company”), a biopharmaceutical company pioneering novel treatments for obesity, today announces the appointment of three new...

BOSTON, April 21, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics,...

Webcast scheduled for Tuesday, April 1, 2025 at 8:00 AM ET. BOSTON, March 31, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused...

Anteris Technologies reaches clinical milestone: 100 patients treated with DurAVR® Transcatheter Heart Valve (THV)

Austin, TX, USA, March 27, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Fabry Disease Treatment Market Size, Trends and Insights By Treatment (Enzyme...

MINNEAPOLIS and BRISBANE, Australia, March 21, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris® or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company...

YPrime earns prestigious EcoVadis rating, reinforcing commitment to sustainable clinical research.

Interim analysis of 1-level BAGUERA®C IDE study meets threshold for non-inferiority Geneva, March 11, 2025 – Spineart, a fast-growing company in spine surgery innovation, today announces that it has...

Austin, TX, USA, March 06, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Refurbished Laboratory Equipment Market Size, Trends and Insights By Product...

YPrime launches eCOA Automated Data Change Form, reimagining clinical trial data management with enhanced efficiency and accuracy.